C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2002
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	US20020170091 Acyl CoA:cholesterol acyltransferase related nucleic acid sequences
11/14/2002	US20020170085 Methyl CpG binding domain nucleic acids from maize
11/14/2002	US20020169308 Nucleotide sequences coding membrane protein for use in the human diagnostics and therapeutics
11/14/2002	US20020169304 Nucleotide sequences coding polypeptide for use in the classification, diagnosis, prevention and treatment of downe's syndrome and alzheimers's diseases
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169214 Methods and compositions for inactivating viruses
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002	US20020168746 Lipolytic enzymes
11/14/2002	US20020168745 Transacylases of the paclitaxel biosynthetic pathway
11/14/2002	US20020168743 Polypeptide for use in as tool in monitoring microbial propagation in high throughput assays
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168738 Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168733 Microbial production of epoxides
11/14/2002	US20020168732 Fermentative generation of amino acid for use in human foods, nutrients and medicine; obtain corynefrom bacteria, transform with nucleotide sequences coding amino acids, express, isolate preferential amino acids
11/14/2002	US20020168731 Nucleotide sequences coding enzymatic polypeptide for use in the generation of threonine
11/14/2002	US20020168730 Epoxidation of a polyketide; obtain genetically engineered cell, incubate with chemical intermediate, epoxide or hydroxide, recover modified polyketide
11/14/2002	US20020168728 Generation preferential proteins; obtain gram-negative prokaryotic cell, transform with nucleotide sequences coding protein, culture, recover protein
11/14/2002	US20020168727 Generation of botulinum neurotoxin light chain; culture cells coding botulinum neurotoxin light chain, express genes, recover protein
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168721 TSG-like gene
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168705 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
11/14/2002	US20020168703 Process for the manufacture of carotenoids and biologically useful materials thereof
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168654 Method and system for modeling cellular metabolism
11/14/2002	US20020168646 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168388 Topical cosmetic composition
11/14/2002	US20020168382 Inducing immunology response
11/14/2002	US20020168380 Moderating immunology response
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002	US20020168363 Integrin/adhesion antagonists
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002	CA2447470A1 Peptide deformylase activated prodrugs
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446819A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446031A1 Process for synthesizing protein using cell-free protein synthesis system
11/14/2002	CA2445997A1 Saponin inactivated mycoplasma vaccine
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445781A1 Peptidylarginine deiminase 6
11/14/2002	CA2445049A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	CA2435142A1 Kinases and phosphatases
11/14/2002	CA2408968A1 Adsorbent for endocrine disruptors and foods and drinks containing the same
11/13/2002	EP1256628A2 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/13/2002	EP1255869A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255859A2 Tissue specific genes of diagnostic import
11/13/2002	EP1255857A2 Method of identifying toxic agents using differential gene expression
11/13/2002	EP1255853A2 Methods of protein destabilization and uses thereof
11/13/2002	EP1255847A2 Alteration of growth and adaptation under hypoxic conditions
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255840A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
11/13/2002	EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255830A2 Cbp86, a sperm specific protein
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255821A2 Protein c derivatives
11/13/2002	EP1255820A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255811A1 Single colonies of myxobacteria cells
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255773A2 Insecticidal proteins from bacillus thuringiensis
11/13/2002	EP1255771A1 Novel compounds
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1003887B1 Use of a virus dna as promoter
11/13/2002	EP0973760B1 Kodaistatins a, b, c and d, a process for their production and their use
11/13/2002	EP0722503B1 Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria
11/13/2002	EP0693940B1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells
11/13/2002	EP0606452B1 Vector vaccines of recombinant feline herpesvirus
11/13/2002	EP0584284B9 Recombinant dna-derived cholera toxin subunit analogs
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379823A Method for production of L-cysteine or L-cysteine derivatives by fermentation
11/13/2002	CN1379822A D-gluconolactone oxidase gene and method for producing recombinant D-gluconolactone oxidase

1 ... 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 ... 1489